{
  "trial_id": "NCT00001221",
  "overall_assessment": "likely_ineligible",
  "inclusion": [
    {
      "criterion": "All subjects will be outpatients.",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "Patients must be females with Turner's syndrome diagnosed by leukocyte karyotype",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "Chronologic age greater than or equal to 5 years.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Prepubertal Tanner I status. If breast development is Tanner II or III, demonstration of castrate status through measurement of serum FSH (greater than 12 MIU/ML).",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "All patients must be below the 10th percentile for chronologic age.",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "Patients must have at least 6 months accurate, growth measurements available for calculation of pre-study growth velocity. Pretreatment measurements must be obtained during a time when the patient is not receiving a potential growth-promoting agent.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Patients judged to be thyroxine deficient must have replacement which has resulted in normal thyroid function tests over the three-month period prior to enrollment (T4, T3, Thyroid Stimulating Hormone).",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Patients and/or parents or legal guardians of patients must sign an informed consent statement. Assent should be obtained from all patients competent to understand the protocol.",
      "label": "met",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "Patients who have received any form of human growth hormone within the past 3 months, or who have received a cumulative course of therapy totaling greater than one year.",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Patients who have received treatment with estrogen or androgen in the past three months or who have received a cumulative course of therapy totaling greater than one year.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Patients who have any Y component in their chromosome analysis.",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Patients with a chronologic age greater than 12 years.",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Patients with a bone age greater than 12 years.",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "Patient is an obese, mentally retarded girl in the physical exam. Her breast bulb were in stage 1 with no course hair in the pubic or axillary.",
  "_meta": {
    "topic_id": "49",
    "trial_id": "NCT00001221",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}